WHEN THIS COMPANY WILL CHANGE THE NAME TO --LEHER FOOTWEAR--OFFICEALY THEN SEE THE MAGIC OF PRICE..
Excise duty cut and GST , all these are beneficial for the company, it should add to the bottomline . Lehar could give multifold return from here.
MARK MY WORD
Very good movement seen in e-land from 31 to 39. it is in the consolidation range between rs 36 to 38. once breakout happens rs 44 plus in the near term. this is one of my favourite stock which gives sharp ups and down. volumes are consistently up which means some accumulations are going on. jul`16 result is the key to see future directions. in november 2016 , this stock will have much clarity. happy investing. cheers.
E-land will fly high in the days to come. some saving to promotors due to new textile policy and its benefits with epf contribution. employee expenses will come down for next three years. textile industries employee are frequently switch jobs.also tax benefits from government for exports also plus point for this stock. since 300 cr exports are agreed for 10 years, its a good boost to the company.
First quarter result will be in the month of jul 16 and expects some improvements in losses and revenue this stock is very unpredictable and bounces to new high levels in the short span of time of course it comes down in the same speed patience is the key tracking this stock from the level of rs 10 - my target for mudra lifestyle is rs 42 for the short term with a stoploss of rs 32
Now expect back to back upper circuits. those who gets a chance to buy are lucky. as said earlier, now it has crossed 39 decisively we will see new highs in the days to come. cheers.
Just relax and enjoy. what a volume increase today in both nse and bse. good news to come. cheers. crossing 39 will take it towards rs 44 plus.
Accumulate this gem at every level,gst will likely to be passed in monsoon session then this stock will fly and very hard to catch at that moment
Yes Friends Pharma has made 3 times revenue in the last quarter, going by same figure if Pharma can make 28cr revenue in 2016-17 should be great, on the 8.57 and 10.57 figure i added other income the figue came to 10.52 but in statement it is 10.57 can raise to CS on the break up , YOY even pharma revenue is down a bit but NP seems to be postive, it will take another year or two to see the pharma benefits
Results update: As expected E-Land Apparels reported loss.
Some positives as below:Revenue has increased 34% from 2015 to 2016. Loss after Tax reduced significantly by 50%.
Some surprises as below:The company had entered into lease cum sale agreement with Karnataka Industrail and Development Board (KIADB) in October 2008 for lease cum sale of an industrial land in Bengaluru.The entering value of the land is 1532.73 Lacs as at March 31,2016. If the application is approved E-Land will have the rights and worth of 1532.73 Lacs of Assets. This is super good news.
E-land apprales has made an agreement of rs 300 crore sale for 10 years starting from 15th march 2016. that means Rs 30 crore business per year and quarterly 7.5 crore business. Future is good as parent company is taking initiative to turn around.
We are going to see improvements from this quarter onwards in revenue as well as profit increase (loss decreasing). the land value is a definitely an asset as mentioned in the results update. in the previous year, the company had entered into an agreement for a sale of assets for one of its units located in daman, the conditions of which subsequently have not been complied with and hence terminated. accordingly the above sale is being reversed and classified as "assets held for sale" to reflect the current status. once this materialised in this financial year , we can see changes in the balance sheet. this stock gives chances of series of upper and lower circuits in the days to come. cheers.
THISH WILL BE A MULTIBAGGER STOCK IN LONG RUN KEEP MY WORDS
Results seem pretty decent to me. Flat topline and bottomline moves from negative to positive. Good news is the Proyurveda vertical doing good in both topline as well as bottomline.
Pharma has made 3 times revenue in the last quarter, going by same figure if Pharma can make 28cr revenue in 2016-17 should be great, on the 8.57 and 10.57 figure i added other income the figue came to 10.52 but in statement it is 10.57 can raise to CS on the break up , YOY even pharma revenue is down a bit but NP seems to be postive, it will take another year or to see the pharma benefits..
